Internal Medicine, Cardiovascular Disease · Reno, NV
NPI
1215129044
Since 2007
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
6
Medicare group memberships
Hospitals
5
Hospital affiliations
1500 E 2nd St Ste 400
Reno, NV, 89502
Phone (775) 982-2400
Groups this clinician bills Medicare through
Medicare paid, 2024
$187K
5,333 services
Medicare patients, 2024
2,352
Average age 75
Drug cost, 2024
$3.6M
9,682 prescriptions
Company payments, 2025
$127K
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Thomas-Duythuc to was code 93010 (electrocardiogram), 1,469 times for 1,233 patients. In total Thomas-Duythuc to billed 5,333 services in 59 codes, and Medicare paid $187K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-12-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93010 Electrocardiogram | Facility | 1,469 | 1,233 | $5.94 | $8,722 |
| 93306 Echocardiography (TTE/TEE) | Facility | 692 | 665 | $47.17 | $33K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 659 | 497 | $12.43 | $8,190 |
| 99214 Office E&M - Established | Facility | 628 | 468 | $69.25 | $43K |
| 93264 External Electrocardiographic Monitoring | Facility | 192 | 41 | $25.75 | $4,944 |
| 99204 Office E&M - New | Facility | 148 | 148 | $95.81 | $14K |
| 93018 Electrocardiogram | Facility | 137 | 137 | $10.24 | $1,402 |
| 99215 Office E&M - Established | Facility | 125 | 104 | $103.74 | $13K |
| 93970 Duplex Scan - Extremity Veins | Facility | 125 | 125 | $24.27 | $3,033 |
| 93971 Duplex Scan - Extremity Veins | Facility | 94 | 91 | $15.48 | $1,455 |
| 78452 Myocardial Perfusion Scan | Facility | 84 | 84 | $56.83 | $4,773 |
| 99214 Office E&M - Established | Office | 79 | 74 | $69.99 | $5,529 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 68 | 65 | $12.12 | $824 |
| 99232 Hospital E&M - Subsequent | Facility | 60 | 47 | $58.43 | $3,506 |
| 93248 Electrocardiogram | Facility | 51 | 50 | $18.91 | $965 |
By year: 2022 $217K for 4,441 services; 2023 $188K for 4,525 services; 2024 $187K for 5,333 services.
Medicare prescription drug claims, 2024
In 2024, the drug Thomas-Duythuc to prescribed most often to Medicare patients was Atorvastatin Calcium, with 994 prescriptions and refills. In total Thomas-Duythuc to wrote 9,682 Medicare prescriptions that cost $3.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 994 | 2,958 | 369 | $18K |
| Jardiance Empagliflozin | 819 | 2,013 | 274 | $1.1M |
| Rosuvastatin Calcium Generic | 790 | 2,371 | 275 | $19K |
| Metoprolol Succinate Generic | 629 | 1,799 | 216 | $14K |
| Spironolactone Generic | 543 | 1,538 | 199 | $6,951 |
| Entresto Sacubitril/Valsartan | 521 | 1,115 | 154 | $706K |
| Losartan Potassium Generic | 515 | 1,513 | 173 | $7,479 |
| Carvedilol Generic | 403 | 1,145 | 146 | $6,619 |
| Eliquis Apixaban | 388 | 907 | 129 | $508K |
| Amlodipine Besylate Generic | 320 | 942 | 113 | $2,495 |
| Metoprolol Tartrate Generic | 254 | 692 | 83 | $2,829 |
| Lisinopril Generic | 251 | 717 | 96 | $2,529 |
| Furosemide Generic | 221 | 576 | 85 | $1,553 |
| Xarelto Rivaroxaban | 214 | 534 | 74 | $289K |
| Clopidogrel Clopidogrel Bisulfate | 201 | 559 | 72 | $3,906 |
Brand drugs: - claims; generic drugs: 6,996 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Thomas-Duythuc to $127K ($127K in general payments such as food, travel and fees) from 15 companies. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $117K.
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 92 | $117K |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $5,044 |
| Lilly USA, LLC LLY | 1 | $1,430 |
| Abbott Laboratories ABT | 15 | $687 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 8 | $469 |
| CVRx, Inc. CVRX | 6 | $464 |
| Novo Nordisk Inc NVO | 4 | $324 |
| Medtronic, Inc. MDT | 2 | $200 |
| Shockwave Medical, Inc JNJ | 2 | $188 |
| Boston Scientific Corporation BSX | 5 | $167 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.